The Union Health Minister Harsh Vardhan has reiterated that India may not require Pfizer’s vaccine against the coronavirus disease (Covid-19), and other candidate vaccines are so far being tested in the country showing promising results. in safety tests. According to media reports, the health minister said it made no sense …
Read More »
By: Bloomberg | November 21, 2020 11:51:38 am Pfizer and state and federal government officials have been preparing to help distribute the vaccine within days of an emergency clearance from the FDA. (Bloomberg) Pfizer Inc. and BioNTech SE applied for emergency clearance for their Covid vaccine on Friday, and it …
Read More »
LONDON: Pfizer Inc said on Wednesday that the final results of the last stage of testing its Covid-19 vaccine show it was 95% effective, adding that it had the required two months of safety data and would request authorization emergency service in a few days. The drug maker said the …
Read More »
By: Reuters | Updated: November 18, 2020 8:21:33 pm The drugmaker said the efficacy of the vaccine, developed with German partner BioNTech SE, was consistent across age and ethnic demographics. Pfizer Inc said Wednesday that final results of the last stage of the trial of its Covid-19 vaccine show that …
Read More »
Pfizer is “very close” to requesting an emergency use approval for its Covid-19 vaccine after collecting safety data to send to US regulators, the company’s chief executive said Tuesday, according to a report. Last week, Pfizer and its partner BioNTech SE reported that an interim analysis showed that their experimental …
Read More »
Written by Prabha Raghavan, Anil Sasi | New Delhi | Updated: November 11, 2020 7:14:52 am Pfizer and German partner BioNTech SE are the first drug manufacturers to show successful data from a large-scale clinical trial of a coronavirus vaccine. While Pfizer and BioNTech await sufficient safety data In late …
Read More »
If the Pfizer vaccine is licensed, the number of doses will initially be limited. Pfizer Inc said Monday that its experimental COVID-19 vaccine was more than 90% effective, a major victory in the fight against a pandemic that has killed more than a million people, hit the global economy and …
Read More »
The American pharmaceutical company Pfizer Inc and the German biotechnology company BioNTech announced today that their mRNA-based covid vaccine candidate BNT162b2 against the coronavirus has demonstrated evidence of efficacy against COVID-19 in participants. This is based on the first interim efficacy analysis conducted on November 8, 2020 by an external …
Read More »
Pfizer Inc said Friday that it could request emergency use of its coronavirus vaccine as soon as a safety milestone is reached in November. The drugmaker should have enough data from its late-stage trial to know if its coronavirus vaccine works for this month, CEO Albert Bourla wrote in an …
Read More »
Some covid vaccine developers may publish interim data from their end-stage trials over the next several weeks. There is no approved COVID-19 vaccine yet, but several are in advanced trials, including those by Pfizer Inc, Johnson & Johnson, AstraZeneca-Oxford University, Novavax, and Moderna. Pfizer and its partner BioNTech could have …
Read More »